231 related articles for article (PubMed ID: 20451962)
1. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
Yamaguchi T; Hasegawa M; Niimi R; Sudo A
Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
[TBL] [Abstract][Full Text] [Related]
2. The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer.
Niimi R; Hasegawa M; Shi DQ; Sudo A
Thromb Res; 2012 Nov; 130(5):759-64. PubMed ID: 22192153
[TBL] [Abstract][Full Text] [Related]
3. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Bawa H; Weick JW; Dirschl DR; Luu HH
J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
[TBL] [Abstract][Full Text] [Related]
4. Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study.
Kawaji H; Ishii M; Tamaki Y; Hamasaki M; Ishikawa H; Sasaki K; Dairaku K; Takagi M
Mod Rheumatol; 2012 Apr; 22(2):216-22. PubMed ID: 21761228
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.
Migita K; Bito S; Nakamura M; Miyata S; Saito M; Kakizaki H; Nakayama Y; Matsusita T; Furuichi I; Sasazaki Y; Tanaka T; Yoshida M; Kaneko H; Abe I; Mine T; Ihara K; Kuratsu S; Saisho K; Miyahara H; Segata T; Nakagawa Y; Kamei M; Torigoshi T; Motokawa S
Arthritis Res Ther; 2014 Jul; 16(4):R154. PubMed ID: 25047862
[TBL] [Abstract][Full Text] [Related]
6. Deep vein thrombosis after total hip arthroplasty and total knee arthroplasty in patients with previous ischemic stroke.
Qin J; Xu Z; Shi D; Chen D; Dai J; Teng H; Jiang Q
Int J Low Extrem Wounds; 2013 Dec; 12(4):316-9. PubMed ID: 24043672
[TBL] [Abstract][Full Text] [Related]
7. Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients.
Ishibe M; Kariya S
Hip Int; 2011; 21(6):684-7. PubMed ID: 22101618
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients.
Gao X; Jin X; Huang R; Li Z; Zhang H; Fan P
BMC Surg; 2024 May; 24(1):162. PubMed ID: 38762739
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
Tran AH; Lee G
Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
[TBL] [Abstract][Full Text] [Related]
10. Is routine chemoprophylaxis necessary for prevention of venous thromboembolism following knee arthroplasty in a low incidence population?
Cho KY; Kim KI; Khurana S; Bae DK; Jin W
Arch Orthop Trauma Surg; 2013 Apr; 133(4):551-9. PubMed ID: 23381297
[TBL] [Abstract][Full Text] [Related]
11. [Influence of body mass index and age on deep vein thrombosis after total hip and knee arthroplasty].
Guan Z; Chen Y; Song Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Jun; 20(6):611-5. PubMed ID: 16827383
[TBL] [Abstract][Full Text] [Related]
12. The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.
Hasegawa M; Wada H; Wakabayashi H; Yoshida K; Miyamoto N; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Uchida A; Sudo A
Clin Chim Acta; 2013 Oct; 425():109-13. PubMed ID: 23876378
[TBL] [Abstract][Full Text] [Related]
13. [Risk factor for residual deep vein thrombosis after fondaparinux administration in patients with postoperative replacement arthroplasty].
Enokiya T; Muraki Y; Iwamoto T; Kawase R; Hasegawa M; Sudo A; Uchida A; Okuda M
Yakugaku Zasshi; 2012; 132(5):683-7. PubMed ID: 22687701
[TBL] [Abstract][Full Text] [Related]
14. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
15. Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.
Reynolds NA; Perry CM; Scott LJ
Drugs; 2004; 64(14):1575-96. PubMed ID: 15233593
[TBL] [Abstract][Full Text] [Related]
16. Changes in LPIA D-dimer levels after total hip or knee arthroplasty relevant to deep-vein thrombosis diagnosed by bilateral ascending venography.
Shiota N; Sato T; Nishida K; Matsuo M; Takahara Y; Mitani S; Murakami T; Inoue H
J Orthop Sci; 2002; 7(4):444-50. PubMed ID: 12181657
[TBL] [Abstract][Full Text] [Related]
17. Deep vein thrombosis after total hip and knee arthroplasty in Indian patients.
Jain V; Dhaon BK; Jaiswal A; Nigam V; Singla J
Postgrad Med J; 2004 Dec; 80(950):729-31. PubMed ID: 15579615
[TBL] [Abstract][Full Text] [Related]
18. Perioperative risk factors for deep vein thrombosis after total hip arthroplasty or total knee arthroplasty.
Shimoyama Y; Sawai T; Tatsumi S; Nakahira J; Oka M; Nakajima M; Jotoku T; Minami T
J Clin Anesth; 2012 Nov; 24(7):531-6. PubMed ID: 23006595
[TBL] [Abstract][Full Text] [Related]
19. Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty.
Sasaki H; Ishida K; Shibanuma N; Tei K; Tateishi H; Toda A; Yamashiro Y; Matsumoto T; Kuroda R; Kurosaka M
Int Orthop; 2014 Mar; 38(3):525-9. PubMed ID: 24100922
[TBL] [Abstract][Full Text] [Related]
20. Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials.
Xing KH; Morrison G; Lim W; Douketis J; Odueyungbo A; Crowther M
Thromb Res; 2008; 123(1):24-34. PubMed ID: 18620740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
